U.S. market Closed. Opens in 3 hours 3 minutes

ALBT | Avalon GloboCare Corp. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 2.1200 - 2.4900
52 Week Range 2.1200 - 21.60
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 360,134
Average Volume 374,935
Shares Outstanding 1,065,610
Market Cap 2,386,966
Sector Real Estate
Industry Real Estate - Services
IPO Date 2018-03-27
Valuation
Profitability
Growth
Health
P/E Ratio -0.11
Forward P/E Ratio N/A
EPS -20.10
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 4
Country USA
Website ALBT
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promote and empower high impact, transformative biotechnology, and their clinical applications, and healthcare facility management. It has three reportable segments: real property operating segment which is the key revenue driver; medical-related consulting services segment; and development services and sales of developed products segment. The company focuses on the diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
ALBT's peers: DUO, UK, ACNDF, ASPZ, ADPPF, AZLCZ, ABCP, AANNF, BREUF, AGTK
*Chart delayed
Analyzing fundamentals for ALBT we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see ALBT Fundamentals page.

Watching at ALBT technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ALBT Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙